MIRTAZAPINE 15mg. IP

An effective and well-tolerated antidepressant for the treatment of patients with moderate to severe major depression. (K J Holm, 1999) An anti-depressant that restores the balance of natural chemicals (neurotransmitters) in the brain. Exerts a faster onset of action than the most frequently used type of antidepressants, such as citalopram, fluoxetine, paroxetine, or sertraline. (Norio Watanabe, 2011) A good choice for depressed patients with significant anxiety or insomnia. (Hartmann, 1999) Provides rapid and sustained improvements in depressive symptoms in patients with major depression, including the elderly. (Katherine F Croom, 2009) An effective drug in the treatment of patients who are resistant or intolerant to selective serotonin reuptake inhibitors. (Hirschfeld, 2002) Shows an advantage over amitriptyline in reducing the risk of relapse and the recurrence of depression. (S A Montgomery, 1998) Improves the sleep quality of major depressive disorder patients and decreases the concomitant use of sleep medications. (Dan Wang, 2014) A cost-effective antidepressant alternative to amitriptyline and fluoxetine for the treatment of depression. (K J Holm B. J., 2000) An effective pharmacotherapy for obsessive-compulsive disorder patients. (Lorrin M Koran, 2005) More effective in reducing anxiety symptoms than paroxetine. (J E Kim, 2011)